Replies to post #87538 on Biotech Values

[iwfal]

MDVN - Dimebon

Doesn't look like Pfizer is going for a disease modification claim (at least for now), judging by dimebon's phase III program.

FWIW it has been reported that MDVN actually stated that they weren't claiming 'disease modification'.